Bank of America
KITE

Bank of America’s Kite Pharma, Inc. KITE Stock Holding History

Bank of America’s Portfolio KITE Stock Details KITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-154,316
Closed -$27.7M – 7512
2017
Q3 		$27.7M Buy
154,316
+128,160
+490% +$17.9M ﹤0.01% 1595
2017
Q2 		$2.71M Sell
26,156
-19,994
-43% -$1.63M ﹤0.01% 3621
2017
Q1 		$3.62M Buy
46,150
+25,135
+120% +$1.55M ﹤0.01% 3335
2016
Q4 		$943K Buy
21,015
+12,566
+149% +$616K ﹤0.01% 4393
2016
Q3 		$472K Sell
8,449
-1,784
-17% -$99.4K ﹤0.01% 4668
2016
Q2 		$512K Sell
10,233
-7,965
-44% -$391K ﹤0.01% 4652
2016
Q1 		$835K Sell
18,198
-15,676
-46% -$759K ﹤0.01% 4226
2015
Q4 		$2.09M Buy
33,874
+3,333
+11% +$235K ﹤0.01% 3759
2015
Q3 		$1.7M Buy
30,541
+14,339
+89% +$902K ﹤0.01% 3909
2015
Q2 		$988K Buy
16,202
+11,076
+216% +$632K ﹤0.01% 4121
2015
Q1 		$296K Buy
5,126
+5,026
+5,026% +$337K ﹤0.01% 4675
2014
Q4 		$6K Buy
+100
New +$4.21K ﹤0.01% 7249

Bank of America's KITE Position: Q4 2017 in Review

Bank of America sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 154,316 shares — an estimated $27.7M sold.

Bank of America first reported a position in KITE in Q4 2014 and held it in 12 quarters. The position peaked at $27.7M in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

  • Bank of America reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
  • Bank of America sold 154,316 Kite Pharma, Inc. shares in Q4 2017, an estimated $27.7M.
  • Bank of America first reported a position in Kite Pharma, Inc. in Q4 2014 and held it in 12 quarters.
  • Bank of America's Kite Pharma, Inc. position peaked at $27.7M in Q3 2017.
  • 0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on Bank of America's 13F filing for Q4 2017, filed 14 Feb 2018.